Gk. Richards et Rf. Gagnon, AN ASSAY OF STAPHYLOCOCCUS-EPIDERMIDIS BIOFILM RESPONSES TO THERAPEUTIC AGENTS, International journal of artificial organs, 16(11), 1993, pp. 777-788
Implant-associated infections tend to become persistent resisting host
defences and antibiotic therapy. Routine clinical laboratory testing
of bacterial isolates in the fluid phase for antibiotic susceptibility
may not be predictive of therapeutic outcomes and therefore a number
of antibiotic regimes have been formulated empirically. The resistance
of implant-associated infections has been ascribed to the production
by bacteria, when adherent to the implant surface, of a shielding matr
ix of polymerized carbohydrates protecting the enclosed bacteria from
immune defences and antibiotics. This complex of surface, bacteria and
matrix is termed a biofilm. We describe a technique to evaluate the e
fficacy of antimicrobial agents directed against biofilm-forming strai
ns of Staphylococcus epidermidis (a major cause of implant infections)
utilizing standardized biofilm preparations formed on glass. The impa
ct of the antimicrobial agents was assessed quantally using the end-po
int of permanent cessation of metabolic activity (cell death) of the e
ntire biofilm determined by the loss of ability to reduce 2,3,5-triphe
nyltetrazolium chloride to a visible red intracellular precipitate of
formazan. The relative rate of action of differing antimicrobial agent
s could be determined by the minimum period of exposure of the biofilm
to the agents that is required to bring about sterilization, the clin
ically relevant marker. A wide range of antimicrobial substances could
be evaluated, including chemical disinfectants, immunoreactive substa
nces, antibiotics; singly and in combination; and the modifying effect
s of interaction with non-antibacterial therapeutic agents and other e
nvironmental factors. The technique is simple, inexpensive, reproducib
le and readily adaptable to the clinical situation where evaluation of
therapeutic regimes for individual Gases of prosthetic device-associa
ted infection is required routinely with despatch and ease of interpre
tation.